This report considers how thalidomide has affected survivors' lives and the lives of their immediate families, what supports are available and what supports they might need.

This chapter reports on the performance of primary and community health services which include general practice, pharmaceutical services, dentistry, allied health services, community health services, maternal and child health and alcohol and other drug treatment.

Opioid use and its associated harms is an issue of great public health interest, both within Australia and internationally. This report shows that opioid harms are an issue in both Australia and Canada. Rates of opioid deaths and opioid poisoning hospitalisations in Australia increased in the last ten years.

Pharmaceutical companies behind some of Australia’s best-known brands avoided an estimated $215 million a year in tax in Australia over a three year period - almost four times the $63 million actually paid, according to this report.

This report provides a cost-benefit analysis of establishing a pharmacy council in Queensland. The report was commissioned following a request from the Health, Communities, Disability Services and Domestic and Family Violence Prevention Committee.